Back

Control of arterial hypertension in the context of metabolically-associated disease: challenges and opportunities in Ukraine

1 September 2024 (16:00 - 16:40)
Organised by: Logo
Congress Presentation Part of: Hypertension around the world Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Taras Chendey

Uzhhorod National University, Uzhgorod (Ukraine)

5 More presentations in this session

Presentation thumbnail
Individual and cumulative effects of socioeconomic factors on hypertension in low- and middle-income countries: a cross-sectional study of 1,071,070 individuals from 26 nationally representative surve
Doctor G. Satheesh (Hyderabad, IN)
Abstract Slides Video
Presentation thumbnail
Trends in hypertension prevalence and control in England over the last 3 decades: Health Survey of England 1994-2019
Doctor J. Steckelmacher (London, GB)
Abstract Slides Video
Presentation thumbnail
Influences of cardiovascular disease on the relationship between baseline systolic blood pressure and adverse outcomes in diabetes: insights from large population-based study
Doctor A. Cai (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Increasing trends in hypertension-related mortality in European Union 27 countries from 2011 to 2019
Doctor A. MAZZA (Adria, IT)
Abstract Slides Video
Presentation thumbnail
Trend in the prevalence, awareness, treatment and control of hypertension among adult over in Nigeria over a 4-year period
Doctor T. Shogade (Uyo, NG)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension around the world

The Event

Event poster

ESC Congress 2024

1 September 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Arterial hypertension in Ukraine: modern challenges and solutions
thumbnail
Congress Presentation
Risk of cardiorenal and metabolic outcomes in inadequately controlled hypertension: insights from the ENLIGHTN study
thumbnail
Congress Session
Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources